The impact of the development of TAVI on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.

Back

ESC Premium Access

The impact of the development of TAVI on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.

Session: Poster session 1 - Aortic valve disease

Topic: Aortic valve disease

Speaker: Professor C. Bouleti (Poitiers, FR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Claire Bouleti

La Miletrie University Hospital Centre, Poitiers (France)

9 presentations

0 follower

28 more presentations in this session

Aortic valve gradient and mortality in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis

Speaker: Doctor G. Witberg (Petah Tikva, IL)

Access

Abstract

Slides

Postprocedural pacemaker rate is related to implantation depth and calcium distribution pattern after Sapien 3 implantation

Speaker: Doctor V. Mauri (Cologne, DE)

Access

Abstract

Endothelial and platelet derived microparticles in patients undergoing transcatheter aortic valve implantation (TAVI)

Speaker: Doctor B. Wernly (Salzburg, AT)

Access

Abstract

Slides

Treatment options in intermediate-high risk patients with aortic stenosis and renal disfunction: the european multicenter propensity match study comparing tavr versus conventional avr surgery

Speaker: Professor C. Muneretto (Brescia, IT)

Access

Abstract

Slides

The incidence and severity of aortic plaque in patients with aortic stenosis and its relation with severity of aortic stenosis

Speaker: Doctor S. Nishimura (Tenri, JP)

Access

Abstract

Slides

Access the full session

Poster session 1 - Aortic valve disease

Speakers: Professor C. Bouleti, Doctor G. Witberg, Doctor V. Mauri, Doctor B. Wernly, Professor C. Muneretto...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources